Sign up
Log in
12 Health Care Stocks Moving In Wednesday's After-Market Session
Share
Listen to the news

Gainers

  • Equillium (NASDAQ:EQ) shares rose 36.0% to $0.53 during Wednesday's after-market session. The company's market cap stands at $18.7 million.
  • Healthcare Triangle (NASDAQ:HCTI) shares rose 30.43% to $0.01. The market value of their outstanding shares is at $4.9 million.
  • Liminatus Pharma (NASDAQ:LIMN) stock increased by 17.01% to $13.0. The market value of their outstanding shares is at $338.1 million.
  • Journey Medical (NASDAQ:DERM) shares rose 8.53% to $7.5. The market value of their outstanding shares is at $174.7 million.
  • Camp4 Therapeutics (NASDAQ:CAMP) shares moved upwards by 7.27% to $1.77. The market value of their outstanding shares is at $35.6 million.
  • Scilex Holding (NASDAQ:SCLX) shares moved upwards by 6.79% to $5.97. The company's market cap stands at $32.7 million.

Losers

  • Helius Medical Tech (NASDAQ:HSDT) stock declined by 53.4% to $0.52 during Wednesday's after-market session.
  • Intensity Therapeutics (NASDAQ:INTS) shares declined by 27.48% to $0.42. The company's market cap stands at $7.7 million.
  • Jupiter Neurosciences (NASDAQ:JUNS) shares fell 24.13% to $1.51. The market value of their outstanding shares is at $49.9 million.
  • Catheter Precision (AMEX:VTAK) shares fell 17.85% to $0.49. The market value of their outstanding shares is at $5.4 million.
  • Simulations Plus (NASDAQ:SLP) shares declined by 13.02% to $23.0. The market value of their outstanding shares is at $462.5 million.
  • Nuwellis (NASDAQ:NUWE) stock declined by 10.28% to $0.33. The market value of their outstanding shares is at $1.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.